Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF CALCIUM CHANNEL BLOCKER FOR INHIBITING EXOSOME SECRETION OR PD-L1 EXPRESSION
Document Type and Number:
WIPO Patent Application WO/2021/085843
Kind Code:
A1
Abstract:
The present invention relates to a use of a calcium channel blocker for inhibiting exosome secretion or PD-L1 expression. It was confirmed that the calcium channel blocker inhibits calcium channels, which are currently known as a target for anticancer drug development, to not only inhibit the secretion of cancer cell-derived exosomes, but also reduce the expression of PD-L1 in cells, and is thus effective for cancer treatment when used in combination with existing anticancer drugs or when used alone in the form of a drug. Accordingly, the present invention can be used in novel modes of anticancer drug development using drugs exhibiting immune-checkpoint inhibition effects and exosome secretion inhibition effects.

Inventors:
BAEK MOON-CHANG (KR)
ALAM RAKIBUL (KR)
IM EUN-JU (KR)
LEE CHAN-HYEONG (KR)
Application Number:
PCT/KR2020/012192
Publication Date:
May 06, 2021
Filing Date:
September 09, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR)
International Classes:
G01N33/50; A61K31/4418; A61K31/4422; A61P35/00
Foreign References:
KR20190088896A2019-07-29
JP2018521038A2018-08-02
KR20150020189A2015-02-25
KR20180133465A2018-12-14
Other References:
ALAM, RAKIBUL: "Studies on the relationship between the calcium channel blockers and the expression of exosomal proteins which are related to immunosuppression in melanoma", THESIS, 1 August 2019 (2019-08-01), pages 1 - 39, XP009527787
KHAN FARMAN MATLOOB, SALEH EKRAM, ALAWADHI HUSSAIN, HARATI RANIA, ZIMMERMANN WOLFRAM-HUBERTUS, EL-AWADY RAAFAT: "Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin", CANCER BIOLOGY & THERAPY, vol. 19, no. 1, 2 January 2018 (2018-01-02), pages 25 - 33, XP055808613, ISSN: 1538-4047, DOI: 10.1080/15384047.2017.1394544
Attorney, Agent or Firm:
TAEBAEK INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: